Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Count down for Ryplazim FDA Decision!

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Apr 18, 2021 11:43am

98 Views

Post# 33018914

RE:Count down for Ryplazim FDA Decision!

StockReddy, do you think that FDA can get a plant inspection complete with the border and lockdowns? It was not done at recent conference call. They didn't say that it was scheduled either so it's a big risk.